Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Merck
Dow
McKinsey

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021148

See Plans and Pricing

« Back to Dashboard

NDA 021148 describes NORDITROPIN NORDIFLEX, which is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the NORDITROPIN NORDIFLEX profile page.

The generic ingredient in NORDITROPIN NORDIFLEX is somatropin. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the somatropin profile page.
Summary for 021148
Tradename:NORDITROPIN NORDIFLEX
Applicant:Novo Nordisk Inc
Ingredient:somatropin
Patents:21
Formulation / Manufacturing:see details
Pharmacology for NDA: 021148
Suppliers and Packaging for NDA: 021148
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORDITROPIN somatropin INJECTABLE;INJECTION 021148 NDA Novo Nordisk 0169-7703 0169-7703-21 1 SYRINGE in 1 CARTON (0169-7703-21) > 3 mL in 1 SYRINGE
NORDITROPIN FLEXPRO somatropin INJECTABLE;INJECTION 021148 NDA Novo Nordisk 0169-7703 0169-7703-21 1 SYRINGE in 1 CARTON (0169-7703-21) > 3 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5MG/1.5ML
Approval Date:Jun 20, 2000TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/1.5ML
Approval Date:Jun 20, 2000TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength15MG/1.5ML
Approval Date:Jun 20, 2000TE:RLD:No

Expired US Patents for NDA 021148

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin INJECTABLE;INJECTION 021148-004 Oct 1, 2004   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148-002 Jun 20, 2000   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin INJECTABLE;INJECTION 021148-006 Oct 1, 2004   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin INJECTABLE;INJECTION 021148-004 Oct 1, 2004   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin INJECTABLE;INJECTION 021148-011 Jan 23, 2015   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148-001 Jun 20, 2000   See Pricing   See Pricing
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148-003 Jun 20, 2000   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Baxter
Merck
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.